A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2006
10/26/2006	WO2006113035A1 Use of lgg in the manufacture of a medicament for the prevention or treatment of respiratory allergies
10/26/2006	WO2006112778A1 New muscarinic receptor antagonists
10/26/2006	WO2006112744A2 Drug composition with analgesic, anti-inflammatory and decongestive activity
10/26/2006	WO2006112365A1 Treatment of pulmonary emphysema with a mesenchymal stem cell
10/26/2006	WO2006111833A1 Functional herbal cigarette in controlling body weight and composition
10/26/2006	WO2006111783A1 Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents
10/26/2006	WO2006111560A2 2,3 substituted pyrazine sulfonamides as inhibitors of crth2
10/26/2006	WO2006111549A1 Dihydrothienopyrimidines for the treatment of inflammatory diseases
10/26/2006	WO2006058867A3 Substituted pteridines for the treatment of inflammatory diseases
10/26/2006	WO2005102301A3 Hydroxymethylbutyrate compositions and uses thereof
10/26/2006	US20060241303 Piperidine derivatives and process for their production
10/26/2006	US20060241132 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient
10/26/2006	US20060241131 Pyrrolo[2,3-d]pyrimidine compounds
10/26/2006	US20060241116 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates
10/26/2006	US20060241112 Kinase inhibitors
10/26/2006	US20060241036 Soluble human interleukin 18 receptor-alpha, method of assaying the same, assay kit and medicinal composition
10/26/2006	US20060241028 Respiratory system disorders; lung hypotensive agents; also pituitary adenylate cyclase activating peptide
10/26/2006	US20060240525 Factor VII or VIIa - Like Molecules
10/26/2006	US20060240524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia
10/26/2006	US20060240113 Anticancer agents; prevent forming blood vessels; removal blockager
10/26/2006	US20060240023 Apoptosis-associated protein and use thereof
10/26/2006	US20060240010 Methods of modulating CD200 receptors
10/26/2006	US20060240000 Combination treatments for allergic disease comprising administering an anti-IgE antibody and antiallergic compound
10/26/2006	US20060239999 Preventive and/or therapeutic drugs for asthma
10/26/2006	US20060239990 Protein Arginine N-Methyltransferase 2 (PRMT-2)
10/26/2006	US20060239927 Drug for airway administration
10/26/2006	US20060237004 Methods for treating trigeminal neuralgia
10/26/2006	US20060237003 Methods for treating headaches
10/26/2006	DE102005019458A1 Composition, useful in the preparation of pellets and the multi-particular-presentation form, comprises cefuroximaxetil and carrageenan of the group of lambda carrageenan, tau carrageenan and kappa carrageenan
10/26/2006	CA2605161A1 Dihydrothienopyrimidines for the treatment of inflammatory diseases
10/26/2006	CA2604846A1 Use of lgg in the manufacture of a medicament for the prevention or treatment of respiratory allergies
10/26/2006	CA2603920A1 Pharmacological treatment for sleep apnea
10/26/2006	CA2601979A1 2,3 substituted pyrazine sulfonamides
10/25/2006	EP1714969A2 Immunostimulatory nucleic acid molecules
10/25/2006	EP1713772A1 Novel piperidines as chemokine modulators (ccr)
10/25/2006	EP1713480A2 The use of quaternary pyridinium salts as vasoprotective agents
10/25/2006	EP1713473A1 The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd
10/25/2006	EP1713472A2 Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
10/25/2006	EP1713471A2 Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
10/25/2006	EP1713463A2 Reelin deficiency or dysfunction and methods related thereto
10/25/2006	EP1713439A1 Pharmaceutical preparation for the oral cavity
10/25/2006	EP1458718B1 Quinolinones as prostaglandin receptor ligands
10/25/2006	EP1265606B1 Cell adhesion inhibitors
10/25/2006	EP1187613B9 Amide substituted imidazoquinolines
10/25/2006	EP1143930B1 Pharmaceutical formulation of fluticasone propionate
10/25/2006	EP1109901B1 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF
10/25/2006	CN1852988A Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation
10/25/2006	CN1852923A Human antibody molecules for IL-13
10/25/2006	CN1852724A Method for the production of a storage-resistant ivy leaf extract, and extract produced according to said method
10/25/2006	CN1852709A Macrophage activation inhibitor
10/25/2006	CN1852708A Human beta-defensin secretion promoter
10/25/2006	CN1850268A Semen caesalpiniae Chinese medicine preparation for treating cold, its preparing method and quality control method
10/25/2006	CN1850249A Composition with function of relieving cough and calming asthma and preparing method
10/25/2006	CN1850241A Dispersible tablet of Vitamin C and Lonicera and Forsythia and preparing method thereof
10/25/2006	CN1850240A Technology for preparing succus Bambusae
10/25/2006	CN1850239A Vitamin C and Lonicera and Forsythia capsule
10/25/2006	CN1850235A Chinese medicine composition for eliminating cough and asthma and preparing method
10/25/2006	CN1850222A Chinese medicine preparation for releasing lung and detoxification
10/25/2006	CN1850204A Medicine composition for resisting exogenous cold and high fever, and its preparing method
10/25/2006	CN1850199A Lung-nourishing preparation and new preparing method
10/25/2006	CN1850194A Patent Chinese medicinal tablet for treating exogenous cold and preparing technology
10/25/2006	CN1850193A Method for preparing capsule of Exocarpium citri Tangerinae seu Grandis and loquat, and its quality control technology
10/25/2006	CN1850190A Ointment for treating rhinitis and preparing method
10/25/2006	CN1850174A Method for preparing Rhizoma cimicifugae formula granules
10/25/2006	CN1850158A Tanshinoue dropping pills and preparing method
10/25/2006	CN1850156A Dropping pill for treating throat disease and preparing method thereof
10/25/2006	CN1850151A Chinese medicinal liquid of acupuncture point cupping for preventing and treating infant's respiration diseases, and preparing method
10/25/2006	CN1850150A Compounded Radix Bupleuri enema preparation and preparing method
10/25/2006	CN1850142A Method for preparing honeysuckle formula granules
10/25/2006	CN1850141A Method for preparing Radix platycodi formula granules
10/25/2006	CN1850132A Herba thesii granules and preparing method therefor
10/25/2006	CN1850118A Earthworm acidic-part medicine for treating cough asthma disease and preparing method
10/25/2006	CN1850093A Stibene-glucoside oral liquid and its production method
10/25/2006	CN1850090A Ambroxol hydrochloride compound slow-release tablet and its preparing method
10/25/2006	CN1850087A Effervescent tablet containing cefixime and its preparing method
10/25/2006	CN1850083A Dispersible tablet for treating cold and its preparing process
10/25/2006	CN1850073A Medicinal composition containing ampicillin and its preparing method
10/25/2006	CN1281608C New azo-indolyl derivatives
10/25/2006	CN1281604C Substituted pyrazole compounds
10/25/2006	CN1281601C Bipyridyl derivatives as a highly selective cyclooxygenase-2 inhibitor
10/25/2006	CN1281588C Novel intermediate for preparation of pyrazolopyrimidinones
10/25/2006	CN1281585C Cyclic diamine compounds having fused-ring groups
10/25/2006	CN1281257C Combination of Chinese herbal medicine for curing chronic tracheitis and chronic bronchitis and application thereof
10/25/2006	CN1281241C Medicine for treating chronic bronchitis and its preparation method
10/25/2006	CN1281233C Orally disintegrating tablet of 'Shuanghuanglian' and its preparation
10/25/2006	CN1281232C Method for preparing compound licorice buccal tablet
10/24/2006	US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/24/2006	US7125985 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
10/24/2006	US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents
10/24/2006	US7125896 Thiophene carboxamide compounds as inhibitors of enzyme IKK-2
10/24/2006	US7125895 Arylalkylamine compounds as chemokine receptor antagonists for therapy and prevention of diseases such as arthritis or rheumatic diseases
10/24/2006	US7125892 Aryl aniline β2 adrenergic receptor agonists
10/24/2006	US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity
10/24/2006	US7125884 N-but-3-enyl norbuprenorphine and its use as analgesic
10/24/2006	US7125881 Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives
10/24/2006	US7125878 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
10/24/2006	US7125875 Cyclic protein tyrosine kinase inhibitors
10/24/2006	US7125866 Therapeutic applications of pro-apoptotic benzodiazepines
10/24/2006	US7125563 Sustained release pharmaceutical preparations and methods for producing the same
10/24/2006	CA2261848C Cell adhesion inhibitors

1 ... 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 ... 878